Physician profile
Eli E Hendel
NPI 1871552661
$3,834.02
in general payments reported to CMS, 2019-2025
22 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $224 · 2021: $470 · 2022: $618 · 2023: $795 · 2024: $524 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,504.59 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $505.85 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $353.23 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $304.11 | 2019-2023 | Breztri |
| Jazz Pharmaceuticals INC. | $281.83 | 2023-2024 | Xywav |
| Novartis Pharmaceuticals Corporation | $145.07 | 2019 | |
| Harmony Biosciences LLC | $115.47 | 2023-2025 | Wakix |
| Acadia Pharmaceuticals INC | $109.65 | 2024 | Nuplazid |
| Phadia US INC. | $86.71 | 2020-2024 | Immunocap |
| Merck Sharp & Dohme LLC | $69.53 | 2019 | |
| Genzyme Corporation | $68.66 | 2019-2024 | |
| Baxter Healthcare | $47.28 | 2023 | Hillrom - Life 2000 Ventilation System |
| Paratek Pharmaceuticals, INC. | $45.02 | 2024 | Nuzyra |
| Electromed, INC. | $29.55 | 2024 | Smartvest |
| Allergan, INC. | $28.32 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $26.71 | 2022 | |
| Mylan Specialty L.P. | $23.61 | 2019 | |
| Analog Devices INC. | $20.41 | 2024 | Sensinel Cpm Wearable |
| Itamar Medical INC | $18.86 | 2021 | |
| Pfizer INC. | $18.72 | 2019 | |
| Gilead Sciences, INC. | $17.90 | 2022 | |
| United Therapeutics Corporation | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Hendel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.